The Wellbeing Neuro Course: A Randomised Controlled Trial of an Online Treatment Program for Adults with Multiple Sclerosis

Not Applicable

Recruiting

• Conditions: Multiple Sclerosis; Depression; Anxiety; Neurological - Multiple sclerosis; Mental Health - Anxiety; Mental Health - Depression

• Registration Number: ACTRN12622000736741
• Lead Sponsor: Dr. Milena Gandy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-05-23
• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

(a) Confirmed diagnosis of Multiple Sclerosis
(b) Experiencing difficulties with their emotional and/or cognitive health
(c) 18+ years of age
(d) Living in Australia

Exclusion Criteria

(a) Imminently suicidal or unable to keep themselves safe
(b) Are experiencing severe cognitive difficulties with day-to-day memory, attention and ability to learn basic information.
(c) Are unable to read and understand English
(d) Do not have access to the internet

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient Health Questionnaire 9-Item (PHQ-9), which is a measure of depression.[ Baseline (pre-intervention), and 6 weeks (mid-intervention), 11 weeks (post-intervention/ primary endpoint), as well as at 3- and 12-months post-intervention commencement.];Generalized Anxiety Disorder 7-Item (GAD-7), which is a measure of anxiety.[ Baseline (pre-intervention), and 6 weeks (mid-intervention), 11 weeks (post-intervention/ primary endpoint), as well as at 3- and 12-months post-intervention commencement.];World Health Organisation Disability Assessment Schedule 2.0 (WHODAS-2), which is a measure of disability associated with living with a chronic health condition.[ Baseline (pre-intervention), and 6 weeks (mid-intervention), 11 weeks (post-intervention/ primary endpoint), as well as at 3- and 12-months post-intervention commencement.]